Chong-Xian Pan, MD; PhD

Adjunct Professor

UC Davis, Hematology and Oncology

Emailcxpan@ucdavis.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Chong-Xian Pan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

11 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Not started
4 Finished

University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
Chen, M., Chen, M., deVere White, R. W., Rocke, D. M., Pan, C. & Lloyd, K. C.
Project: Research project
Potentiation of Immunotherapy with targeted nanoporphyrin in bladder cancer
Pan, C.
Project: Research project
Targeted- and timed-releasing nanotherapeutics against leukemia stem cells
Pan, C.
National Institutes of Health
4/15/15 → 3/31/20
Project: Research project
Development of targeting nanotherapeutics against bladder cancer
Pan, C.
National Institutes of Health
10/1/13 → 9/30/17
Project: Research project
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
Lara, P. N. & Pan, C.
National Institutes of Health
8/1/11 → 7/31/16
Project: Research project

3766 Citations
34 h-Index
94 Article
3 Review article
1 Chapter

Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells
Miranda, M. A., Marcato, P. D., Mondal, A., Chowdhury, N., Gebeyehu, A., Surapaneni, S. K., Bentley, M. V. L. B., Amaral, R., Pan, C. X. & Singh, M., Feb 2021, In: Materials Science and Engineering C. 119, 111460.
Research output: Contribution to journal › Article › peer-review
Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis
Katleba, K., Lombard, A. P., Tsamouri, M. M., Baek, H. B., Nishida, K. S., Libertini, S. J., Platero, A. J., Ma, A. H., Pan, C. X., Ghosh, P. M. & Mudryj, M., Apr 28 2021, In: Cancer Letters. 504, p. 49-57 9 p.
Research output: Contribution to journal › Article › peer-review
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
Parikh, M., Liu, C., Wu, C. Y., Evans, C. P., Dall’Era, M., Robles, D., Lara, P. N., Agarwal, N., Gao, A. C. & Pan, C. X., Dec 2021, In: Scientific reports. 11, 1, 6377.
Research output: Contribution to journal › Article › peer-review

Open Access
A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models
Amaral, R., Zimmermann, M., Ma, A. H., Zhang, H., Swiech, K. & Pan, C. X., May 2020, In: Cancers. 12, 5, 1304.
Research output: Contribution to journal › Article › peer-review

Open Access
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
Long, Q., Ma, A. H., Zhang, H., Cao, Z., Xia, R., Lin, T. Y., Sonpavde, G. P., de Vere White, R., Guo, J. & Pan, C. X., Jan 1 2020, (Accepted/In press) In: Cancer Immunology, Immunotherapy.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations